Lyle Murphy
Medical · Galesburg, ILNPI 1235324450
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $31.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$952
- Boehringer Ingelheim$686
- Amgen$611
- Bayer$383
- GSK$353
- plus $3K from 17 others
What the payments were for
- Food & beverage$6,756100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $1,022 |
| AstraZeneca | 23 | $952 |
| Boehringer Ingelheim | 30 | $686 |
| Amgen | 19 | $611 |
| Bayer | 22 | $383 |
| GSK | 3 | $353 |
| Sanofi-aventis U.S. LLC | 13 | $348 |
| Novartis | 18 | $342 |
| AbbVie | 10 | $294 |
| Sanofi | 2 | $254 |
| Biohaven Pharmaceuticals, Inc. | 6 | $236 |
| Corcept Therapeutics | 3 | $153 |
| Abbott | 9 | $143 |
| Insulet Corporation | 2 | $138 |
| Pfizer | 5 | $134 |
| Viatris Specialty LLC | 6 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $124 |
| Mylan Specialty L.p. | 1 | $123 |
| Exact Sciences | 1 | $118 |
| Eisai Inc. | 2 | $112 |
| Johnson & Johnson | 2 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Lilly USA, LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,756 in reported general payments places this provider in the 90th percentile of 449 medical providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 259 | $206,142 |
| EliquisApixaban | 159 | $173,848 |
| OzempicSemaglutide | 104 | $110,170 |
| XareltoRivaroxaban | 55 | $58,610 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 48 | $32,286 |
| TradjentaLinagliptin | 41 | $29,754 |
| RybelsusSemaglutide | 19 | $29,312 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 38 | $27,996 |
| EntrestoSacubitril/Valsartan | 19 | $20,371 |
| FarxigaDapagliflozin Propanediol | 22 | $19,916 |
| TrulicityDulaglutide | 23 | $18,815 |
| MounjaroTirzepatide | 17 | $17,277 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 28 | $15,258 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $14,875 |
| JanuviaSitagliptin Phosphate | 18 | $11,522 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $686 | $235,896300 claims |
| PfizerEliquis | $134 | $173,848159 claims |
| Novo NordiskOzempic, Rybelsus, Xultophy 100-3.6 | $1,022 | $146,306137 claims |
| Johnson & JohnsonXarelto | $57 | $58,61055 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $353 | $57,464107 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $22 | $36,09240 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $348 | $27,99638 claims |
| AstraZenecaFarxiga, Symbicort | $952 | $25,02534 claims |
| NovartisEntresto | $342 | $20,37119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 449 medical providers in Illinois.
Other medical in Galesburg
- Andrea TurekChicago$145K
- Priya BediElmhurst$56K
- Jennifer GarsonChicago$32K
- Bernice JohnsonPalos Heights$32K
- William KvasnickaChicago$19K
- Katie SpringerLake Forest$17K
- Matthew BrunoMorris$17K
- Kelly BrawleyBarrington$14K
- Megan GriggsSpringfield$13K
- Marianne RaoAlgonquin$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.